These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33637979)

  • 21. The feasibility and limitation of coronary computed tomographic angiography imaging to identify coronary lipid-rich atheroma in vivo: Findings from near-infrared spectroscopy analysis.
    Kitahara S; Kataoka Y; Miura H; Nishii T; Nishimura K; Murai K; Iwai T; Nakamura H; Hosoda H; Matama H; Doi T; Nakashima T; Honda S; Fujino M; Nakao K; Yoneda S; Nishihira K; Kanaya T; Otsuka F; Asaumi Y; Tsujita K; Noguchi T; Yasuda S
    Atherosclerosis; 2021 Apr; 322():1-7. PubMed ID: 33706078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Evolocumab on Coronary Plaque Composition.
    Nicholls SJ; Puri R; Anderson T; Ballantyne CM; Cho L; Kastelein JJP; Koenig W; Somaratne R; Kassahun H; Yang J; Wasserman SM; Honda S; Shishikura D; Scherer DJ; Borgman M; Brennan DM; Wolski K; Nissen SE
    J Am Coll Cardiol; 2018 Oct; 72(17):2012-2021. PubMed ID: 30336824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discordant response of low-density lipoprotein cholesterol and lipoprotein(a) levels to monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9.
    Edmiston JB; Brooks N; Tavori H; Minnier J; Duell B; Purnell JQ; Kaufman T; Wojcik C; Voros S; Fazio S; Shapiro MD
    J Clin Lipidol; 2017; 11(3):667-673. PubMed ID: 28506388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial Changes in Coronary Plaque Formation Using CT Angiography in Patients Undergoing PCSK9-Inhibitor Therapy With 1-year Follow-up.
    Baumann S; Kettel L; Stach K; Özdemir GH; Renker M; Tesche C; Becher T; Hetjens S; Schoepf UJ; Akin I; Borggrefe M; Krämer BK; Schoenberg SO; Janssen S; Overhoff D; Lossnitzer D
    J Thorac Imaging; 2022 Sep; 37(5):285-291. PubMed ID: 35797638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Confirmation of the Intracoronary Near-Infrared Spectroscopy Threshold of Lipid-Rich Plaques That Underlie ST-Segment-Elevation Myocardial Infarction.
    Madder RD; Puri R; Muller JE; Harnek J; Götberg M; VanOosterhout S; Chi M; Wohns D; McNamara R; Wolski K; Madden S; Sidharta S; Andrews J; Nicholls SJ; Erlinge D
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1010-5. PubMed ID: 26941016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-rich plaques detected by near-infrared spectroscopy predict coronary events irrespective of age: A Lipid Rich Plaque sub-study.
    Bambagioni G; Di Mario C; Torguson R; Demola P; Ali Z; Singh V; Skinner W; Artis A; Cate TT; Zhang C; Garcia-Garcia HM; Doros G; Mintz GS; Waksman R
    Atherosclerosis; 2021 Oct; 334():17-22. PubMed ID: 34455112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimodality imaging to identify lipid-rich coronary plaques and predict periprocedural myocardial injury: Association between near-infrared spectroscopy and coronary computed tomography angiography.
    Ota H; Matsuo H; Imai S; Nakashima Y; Kawase Y; Okubo M; Takahashi H; Kawai H; Sobue Y; Kawasaki M; Kondo T; Muramatsu T; Izawa H
    Front Cardiovasc Med; 2023; 10():1127121. PubMed ID: 37077746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship among extent of lipid-rich plaque, lesion characteristics, and plaque progression/regression in patients with coronary artery disease: a serial near-infrared spectroscopy and intravascular ultrasound study.
    Dohi T; Maehara A; Moreno PR; Baber U; Kovacic JC; Limaye AM; Ali ZA; Sweeny JM; Mehran R; Dangas GD; Xu K; Sharma SK; Mintz GS; Kini AS
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):81-7. PubMed ID: 25190072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Atorvastatin (10 mg) and Ezetimibe (10 mg) Combination Compared to Atorvastatin (40 mg) Alone on Coronary Atherosclerosis.
    Oh PC; Jang AY; Ha K; Kim M; Moon J; Suh SY; Lee K; Han SH; Kang WC
    Am J Cardiol; 2021 Sep; 154():22-28. PubMed ID: 34238445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial.
    Rubino J; MacDougall DE; Sterling LR; Kelly SE; McKenney JM; Lalwani ND
    J Clin Lipidol; 2021; 15(4):593-601. PubMed ID: 34172394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stabilization of High Risk Coronary Plaque on Optical Coherence Tomography and Near-Infrared Spectroscopy by Intensive Lipid-Lowering Therapy With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor.
    Ino Y; Kubo T; Shimamura K; Takahata M; Matsuo Y; Kitabata H; Shiono Y; Wada T; Terada K; Katayama Y; Emori H; Higashioka D; Tanaka A; Hozumi T; Akasaka T
    Circ J; 2019 Jul; 83(8):1765. PubMed ID: 30799312
    [No Abstract]   [Full Text] [Related]  

  • 33. NMR-based lipoprotein analysis for patients with severe hypercholesterolemia undergoing lipoprotein apheresis or PCSK9-inhibitor therapy (NAPALI-Study).
    Schettler VJ; Muellendorff F; Schettler E; Platzer C; Norkauer S; Julius U; Neumann CL
    Ther Apher Dial; 2019 Oct; 23(5):467-473. PubMed ID: 30663261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic PCSK9 inhibitor therapy leads to sustained improvements in endothelial function, arterial stiffness, and microvascular function.
    Schremmer J; Busch L; Baasen S; Heinen Y; Sansone R; Heiss C; Kelm M; Stern M
    Microvasc Res; 2023 Jul; 148():104513. PubMed ID: 36870561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-World Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i) in Heterozygous Familial Hypercholesterolemia Patients Referred for Lipoprotein Apheresis.
    Matta A; Bongard V; Bouisset F; Taraszkiewicz D; Rabès JP; Ferrières J
    Med Sci Monit; 2021 May; 27():e928784. PubMed ID: 33958572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions.
    Zhang S; Li ZF; Shi HW; Zhang WJ; Sui YG; Li JJ; Dou KF; Qian J; Wu NQ
    Front Cardiovasc Med; 2022; 9():859567. PubMed ID: 35620524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-world treatment patterns of PCSK9 inhibitors among patients with dyslipidemia in Germany, Spain, and the United Kingdom.
    Tai MH; Shepherd J; Bailey H; Williams N; Hatz M; Campos Tapias I; Catterick D; Worth G
    Curr Med Res Opin; 2019 May; 35(5):829-835. PubMed ID: 30289004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
    Hong YJ; Jeong MH; Hachinohe D; Ahmed K; Choi YH; Cho SH; Hwang SH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Circ J; 2011; 75(2):398-406. PubMed ID: 21157106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of clinical presentations on lipid core plaque assessed by near-infrared spectroscopy intravascular ultrasound.
    Tateishi K; Kitahara H; Saito Y; Kadohira T; Saito K; Matsuoka T; Mori N; Nakayama T; Fujimoto Y; Kobayashi Y
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1151-1158. PubMed ID: 33205339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of statin intervention on mild coronary plaque progression assessed by serial coronary CT angiography].
    Li ZN; Hou ZH; Liu K; Wang ZQ; Yin WH; Gao Y; Xu HY; Jiang SL; Lyu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jun; 44(6):508-12. PubMed ID: 27346264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.